Home  /  Resource Library  /  Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT

Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT

Study investigated CAR-T brexucabtagene autoleucel for treatment of elderly patients with MCL.